Tesamorelin

Price range: £25.00 through £70.00

CAS No: 218949-48-5

Strengths Available: 5mg/10mg
Format: Sealed containment / vial presentations available
Volume: 3mL

What This Product Is About
Tesamorelin is frequently referenced in research exploring growth hormone (GH) and insulin-like growth factor (IGF) signalling pathways. It has attracted scientific interest as a research tool for studying how the body’s GH-axis is regulated under controlled laboratory conditions.

SKU: N/A Category:

Description

What is Tesamorelin?

Tesamorelin is a research-grade peptide studied in the context of growth hormone secretagogue and GH-axis signalling research. Investigators have explored how Tesamorelin interacts with receptors and pathways involved in the regulation of growth hormone and downstream IGF activity.

Why Researchers Became Interested in Tesamorelin

Researchers became interested in Tesamorelin because of its relevance to GH-axis regulation and the broader study of metabolic and recovery pathways. It provides a defined research tool for examining growth-factor signalling in experimental models.

Key Research Focus Areas

  • Growth hormone secretagogue signalling models
  • GH / IGF-1 axis regulation studies
  • Metabolic and body-composition research models
  • Receptor-binding and pathway studies
  • Recovery and tissue-maintenance research
  • Endocrine signalling investigations

What the Research Has Shown

In preclinical research, Tesamorelin has been studied for its influence on growth hormone signalling pathways and related downstream activity. Mechanistic studies have explored its interaction with receptors involved in the regulation of the GH-axis.

Fast Secure Shipping
Independently Verified
Trusted by 1000s of customers
Manufactured in the U.K.

Scientific Background and Research Context

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone, developed for research into the regulation of the growth hormone and insulin-like growth factor 1 axis. Its amino-acid sequence is based on naturally occurring growth hormone-releasing hormone, with a structural modification designed to improve stability against enzymatic degradation.

Scientific interest in tesamorelin centres on its ability to stimulate the pituitary release of endogenous growth hormone. This makes it a useful research compound for studying neuroendocrine signalling, body-composition regulation and the physiological relationship between growth hormone and IGF-1.

Exploring the Science Behind

Tesamorelin interacts with growth hormone-releasing hormone receptors in the anterior pituitary. This receptor activation promotes pulsatile growth hormone secretion, which can subsequently increase hepatic and peripheral IGF-1 signalling.

Researchers examine how this pathway affects lipid metabolism, adipose-tissue distribution, protein turnover and cellular repair. Unlike compounds that directly provide growth hormone, tesamorelin is studied for its ability to act through the body’s endogenous regulatory pathway.

Clinical and laboratory research has also explored its effects on visceral adipose tissue and other markers of body composition. These findings are specific to the populations and conditions studied and should not be generalised beyond the available evidence.

Research Context in Endocrine and Metabolic Science

The growth hormone–IGF-1 axis plays an important role in endocrine regulation, lipid metabolism, glucose homeostasis and tissue maintenance. Tesamorelin is therefore studied in metabolic research involving visceral adiposity, liver fat, muscle composition and broader changes in body composition.

Research has examined its biological effects in people with HIV-associated abdominal fat accumulation and in other controlled metabolic study settings. These investigations contribute to a better understanding of how growth hormone-releasing pathways influence adipose tissue, hepatic metabolism and systemic endocrine function.

Ongoing Scientific Interest

Tesamorelin continues to attract scientific interest in neuroendocrinology, adipose-tissue biology, metabolic regulation and growth hormone signalling. Researchers are examining individual variability in response, changes in visceral and hepatic fat, and the relationship between body-composition changes and metabolic markers.

Further investigation is needed to clarify its longer-term biological effects and its relevance across different research populations. Tesamorelin is supplied strictly for laboratory and research purposes and is not intended for human consumption or therapeutic use.

Ingredient Profile
Single research compound: Tesamorelin
CAS: 218949-48-5
Purity >99%
Supplied as lyophilised powder (no excipients, fillers or additives).

Active Ingredients
Tesamorelin — 5mg/10mg

Ingredient Breakdown
Tesamorelin : 5mg/10mg of active peptide per vial (lyophilised).

Why is Tesamorelin studied in growth-hormone research?
Because studies have explored its relevance to growth hormone and IGF-axis signalling pathways.

Is Tesamorelin approved for medical use?
No. It is supplied strictly for research and laboratory use only, and is not intended for human or veterinary use.

Why does purity matter so much for this product?
High purity helps ensure that observed research effects are due to the material itself rather than impurities.

What does ‘research grade’ mean?
It means the product is supplied with documentation and traceability for laboratory investigation.

Is international supply available?
Yes. International fulfilment and temperature-controlled shipping can be supported where appropriate.

Research & laboratory use only. Not for human or veterinary use. Not a medicinal product, supplement, food or medical device. No therapeutic, diagnostic, cosmetic, wellness or lifestyle claims are made or implied. Analytical reference/click information is a laboratory measurement aid only and must not be applied to living systems.

Typically supplied at >99% purity, supported by batch-specific analytical data. UK-based preparation, analysis and release under scientist-led, GMP-aligned processes with full batch-level traceability. Certificate of Analysis (CoA) available on request; independent analytical verification where appropriate.

Store the lyophilised powder refrigerated at 2–8°C, protected from light and moisture; suitable for longer-term storage frozen at -20°C. Handle under appropriate laboratory conditions. For in vitro research use only.

For in vitro laboratory research only. Reconstitution, handling and experimental design at the discretion of the qualified researcher. The 300-click sealed-containment system is an analytical measurement reference only and does not represent dosing or administration guidance. Not for use in living systems.

Partner with FreshstartPharma– Where Accuracy Meets Innovation

Freshstartpharma is committed to delivering high-quality research-grade products designed for advanced scientific applications. We offer wholesale partnerships to selected businesses that share our values of integrity, quality, and innovation. Whether you’re an established distributor or an emerging research supply company, we invite you to join our network and benefit from exclusive access to our state-of-the-art product range.